Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Operas
6
Administración de personal
5
Internet en la educación
4
Enseñanza con ayuda de computadoras
3
Historia
3
Música barroca
3
Música instrumental
3
Administración
2
Autores mexicanos
2
Capital humano
2
Cirugía
2
Derechos humanos
2
Diseño
2
Educación
2
Educación superior
2
Innovaciones tecnológicas
2
Misa (Música)
2
Motetes
2
Música - Siglo XIX
2
Música de cámara
2
Música orquestal
2
Música para órgano
2
Música sacra
2
Sinfonías
2
Sonatas (Violín)
2
Suites (Violín)
2
Adaptabilidad (Psicología)
1
Aeronáutica en agricultura
1
Anatomía
1
Antigüedades
1
-
83721por Gogas, Helen, Kotoula, Vassiliki, Alexopoulou, Zoi, Christodoulou, Christos, Kostopoulos, Ioannis, Bobos, Mattheos, Raptou, Georgia, Charalambous, Elpida, Tsolaki, Eleftheria, Xanthakis, Ioannis, Pentheroudakis, George, Koutras, Angelos, Bafaloukos, Dimitrios, Papakostas, Pavlos, Aravantinos, Gerasimos, Psyrri, Amanda, Petraki, Kalliopi, Kalogeras, Konstantine T., Pectasides, Dimitrios, Fountzilas, George“…The most consistent finding in the entire cohort and in the above patient subgroups with respect to outcome was the unfavourable effect of MYC CN gain, which was retained upon multivariable analysis (e.g., survival in the entire cohort, HR 6.02; 95 % CI 2.67–13.6; p < 0.001). Further unfavourable prognosticators were increased CEN CN in one chromosome in R-mBC but not in de novo mBC (multivariable interaction p = 0.048), PI3K activation in R-mBC (multivariable p = 0.004) and increased Ki67 for patient TTP. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83722por Ghasemzadeh, Zahra, Abdi, Hengameh, Asgari, Samaneh, Tohidi, Maryam, Khalili, Davood, Valizadeh, Majid, Moeini, Siamak, Eidkhani, Vahid, Azizi, Fereidoun, Hadaegh, Farzad“…Applying lipid measures as categorical variables, only TC displayed a positive association with CV mortality in multivariate analysis [TC ≥ 6.14 mmol/L: HR 1.43 (1.04–1.98)]. In multivariate analysis, there were negative significant associations between all lipid measures except HDL-C and non-CV mortality; every 1-SD increase in TC, LDL-C, non-HDL-C, ln-TGs ,TC/HDL-C and ln-TGs/HDL-C was associated with 24, 25, 27, 19, 23 and 17 % decreased risk in non-CV mortality (all p-values ≤ 0.01). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83723por Ngo-Giang-Huong, Nicole, Wittkop, Linda, Judd, Ali, Reiss, Peter, Goetghebuer, Tessa, Duiculescu, Dan, Noguera-Julian, Antoni, Marczynska, Magdalena, Giacquinto, Carlo, Ene, Luminita, Ramos, Jose T., Cellerai, Cristina, Klimkait, Thomas, Brichard, Benedicte, Valerius, Niels, Sabin, Caroline, Teira, Ramon, Obel, Niels, Stephan, Christoph, de Wit, Stéphane, Thorne, Claire, Gibb, Diana, Schwimmer, Christine, Campbell, Maria Athena, Pillay, Deenan, Lallemant, Marc“…In multivariable analysis, age was associated with a higher risk of VF with a 12 % reduced risk per additional year (HR 0.88; 95 %CI, 0.82–0.95; P < 0.001). CONCLUSIONS: PDR was not significantly associated with a higher risk of VF in children in the first year of cART. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83724por Voudris, Konstantinos V., Wong, S. Chiu, Kaple, Ryan, Kampaktsis, Polydoros N., de Biasi, Andreas R., Weiss, Jonathan S., Devereux, Richard, Krieger, Karl, Kim, Luke, Swaminathan, Rajesh V., Feldman, Dmitriy N., Singh, Harsimran, Skubas, Nikolaos J., Minutello, Robert M., Bergman, Geoffrey, Salemi, Arash“…On multivariate analysis, the only factor significantly associated with one-year mortality was prior history of stroke (HR, 2.76; 95% CI, 1.06-7.17, p = 0.037). CONCLUSION: Despite the higher baseline clinical risk profile, patients with history of prior CABG undergoing TA-TAVR had comparable in-hospital, 6 months and one-year clinical outcomes to those without prior CABG.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83725por Witkowski, Benoit, Duru, Valentine, Khim, Nimol, Ross, Leila S, Saintpierre, Benjamin, Beghain, Johann, Chy, Sophy, Kim, Saorin, Ke, Sopheakvatey, Kloeung, Nimol, Eam, Rotha, Khean, Chanra, Ken, Malen, Loch, Kaknika, Bouillon, Anthony, Domergue, Anais, Ma, Laurence, Bouchier, Christiane, Leang, Rithea, Huy, Rekol, Nuel, Grégory, Barale, Jean-Christophe, Legrand, Eric, Ringwald, Pascal, Fidock, David A, Mercereau-Puijalon, Odile, Ariey, Frédéric, Ménard, Didier“…In 725 patients treated with dihydroartemisinin–piperaquine, multicopy plasmepsin 2 in the sample collected before treatment was associated with an adjusted hazard ratio (aHR) for treatment failure of 20·4 (95% CI 9·1–45·5, p<0·0001). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83726por Kabbach, Erika Zavaglia, Mazzuco, Adriana, Borghi-Silva, Audrey, Cabiddu, Ramona, Agnoleto, Aline Galvão, Barbosa, Jessica Fernanda, de Carvalho Junior, Luiz Carlos Soares, Mendes, Renata Gonçalves“…The GAE patients were evaluated 24–48 hours after starting standard therapy for COPD exacerbation during hospitalization; the GSta patients were evaluated in an outpatient clinic and included in the study if no decompensation episodes had occurred during the previous month. The heart rate (HR) and R-wave peak detection intervals in ms (RRi) were registered using a heart rate monitor (Polar(®) system) at rest in seated position during 10 minutes. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83727por Zelenetz, Andrew D., Barrientos, Jacqueline C., Brown, Jennifer R., Coiffier, Bertrand, Delgado, Julio, Egyed, Miklós, Ghia, Paolo, Illés, Árpád, Jurczak, Wojciech, Marlton, Paula, Montillo, Marco, Morschhauser, Franck, Pristupa, Alexander S., Robak, Tadeusz, Sharman, Jeff P., Simpson, David, Smolej, Lukáš, Tausch, Eugen, Adewoye, Adeboye H., Dreiling, Lyndah K., Kim, Yeonhee, Stilgenbauer, Stephan, Hillmen, Peter“…Median (95% CI) PFS was 20·8 (16·6, 26·4) and 11·1 (8·9, 11·1) months in the idelalisib and placebo arms, respectively (hazard ratio [HR], 0·33; 95% CI, 0·25, 0·44; P<0·0001) at a median (Q1, Q3) follow-up of 14 (7, 18) months. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83728por Wagner, Sandra, Metzger, Marie, Flamant, Martin, Houillier, Pascal, Haymann, Jean-Philippe, Vrtovsnik, François, Thervet, Eric, Boffa, Jean-Jacques, Massy, Ziad A., Stengel, Bénédicte, Rossignol, Patrick“…Considering time-varying P(K) did not materially change these findings, except for the HR of ESKD associated with high P(K), 1.39 [1.09–1.78]. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83729por Holstein, Sarah A., Jung, Sin-Ho, Richardson, Paul G., Hofmeister, Craig C., Hurd, David D., Hassoun, Hani, Giralt, Sergio, Stadtmauer, Edward A., Weisdorf, Daniel J., Vij, Ravi, Moreb, Jan S., Callander, Natalie S., van Besien, Koen, Gentile, Teresa G., Isola, Luis, Maziarz, Richard T, Bashey, Asad, Landau, Heather, Martin, Thomas, Qazilbash, Muzaffar H, Rodriguez, Cesar, McClune, Brian, Schlossman, Robert L., Smith, Scott E., Hars, Vera, Owzar, Kouros, Jiang, Chen, Boyd, Molly, Schultz, Chelsea, Wilson, Marcia, Hari, Parameswaran, Pasquini, Marcelo C., Horowitz, Mary M., Shea, Thomas C., Devine, Steven M., Linker, Charles, Anderson, Kenneth C., McCarthy, Philip L.“…FINDINGS: The median TTP for lenalidomide is 57·3 months (95% CI 44·2–73·3) and 28·9 months (95% CI 23·0–36·3) for placebo (hazard ratio (HR): 0·57, 95% CI 0·46–0·71, p<0·0001). The TTP benefit with lenalidomide was observed regardless of whether patients were in a complete response at time of randomisation or whether they had received thalidomide or lenalidomide induction therapy. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83730por Yao, Ji-Jin, Zhou, Guan-Qun, Wang, Ya-Qin, Wang, Si-Yang, Zhang, Wang-Jian, Jin, Ya-Nan, Zhang, Fan, Li, Li, Liu, Li-Zhi, Cheng, Zhi-Bin, Ma, Jun, Qi, Zhen-Yu, Sun, Ying“…Multivariate analysis confirmed the prognostic value of this model for distant metastatic risk stratification (hazard ratio [HR], 4.17; 95% confidence interval [CI] 2.34–7.59; P < 0.001). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83731por Vetterlein, Malte W., Roschinski, Julia, Gild, Philipp, Marks, Phillip, Soave, Armin, Doh, Ousman, Isbarn, Hendrik, Höppner, Wolfgang, Wagner, Walter, Shariat, Shahrokh F., Brausi, Maurizio, Büscheck, Franziska, Sauter, Guido, Fisch, Margit, Rink, Michael“…In multivariable analyses, Ki-67 labeling index >40% remained an independent predictor of DFS [hazard ratio (HR), 2.66; 95% confidence interval (CI), 1.02–6.95; P=0.046], after adjusting for p53 expression and lymphovascular invasion. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83732por Turkova, Anna, Moore, Cecilia L., Butler, Karina, Compagnucci, Alexandra, Saïdi, Yacine, Musiime, Victor, Nanduudu, Annet, Kaudha, Elizabeth, Cressey, Tim R., Chalermpantmetagul, Suwalai, Scott, Karen, Harper, Lynda, Montero, Samuel, Riault, Yoann, Bunupuradah, Torsak, Volokha, Alla, Flynn, Patricia M., Bologna, Rosa, Ramos Amador, Jose T., Welch, Steven B., Nastouli, Eleni, Klein, Nigel, Giaquinto, Carlo, Ford, Deborah, Babiker, Abdel, Gibb, Diana M.“…Median follow-up was 185.3 weeks (IQR 160.9–216.1). 69 (70%) SCT participants remained on SCT at last follow-up. 105 (53%) were male, baseline median age 14 years (IQR 12–18), median CD4 count 735 cells/μL (IQR 576–968). 16 SCT and 16 CT participants had confirmed VL≥50 copies/mL by the end of extended follow-up (HR 1.00, 95% CI 0.50–2.00). Estimated difference in percentage with viral rebound (SCT minus CT) by week 144 was 1.9% (90% CI -6.6–10.4; p = 0.72) and was similar in a per-protocol analysis. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83733por Büttner, Florian, Winter, Stefan, Rausch, Steffen, Hennenlotter, Jörg, Kruck, Stephan, Stenzl, Arnulf, Scharpf, Marcus, Fend, Falko, Agaimy, Abbas, Hartmann, Arndt, Bedke, Jens, Schwab, Matthias, Schaeffeler, Elke“…RESULTS: The S3(97)-score was significantly associated with cancer-specific survival (CSS) in 52 ccRCC patients (HR 2.9, 95% Cl 1.0–8.0, P(Log-rank) = 3.3 × 10(–2)) as well as progression-free survival in sunitinib-treated patients (2.1, 1.1–4.2, P(Log-rank) = 2.2 × 10(–2)). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83734por Liu, Shuangzhu, Han, Jingjing, Gong, Huanle, Li, Yongsheng, Bao, Xiebing, Qi, Jiaqian, Liu, Hong, Chen, Jia, Wu, Xiaojin, Xu, Yang, Ma, Shoubao, Wu, Depei“…Multivariate analysis confirmed that low sIL-27Rα level (HR = 2.83 95% CI 1.29–6.19, P < 0.01) was an independent risk factor for predicting grade II-IV aGVHD. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83735por Wei, Kai, Nyunt, Ma-Shwe-Zin, Gao, Qi, Wee, Shiou-Liang, Yap, Keng-Bee, Ng, Tze-Pin“…The mortality rate was lowest in the R-NN group (0.54 per 100 person-years) and highest in the PFF-ARM group (3.04 per 100 person-years) (HR, 1.72; 95% CI, 1.01-2.92). The results based on the Nutrition Screening Initiative measure of nutritional status were similar. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83736“…RESULTS: Twenty-five soldiers (72 ± 10 kg) (Mean ± SD) completed the march in 09:11 ± 00:43 (hr:min). Participants consumed 736 ± 259 ml/h of water and lost 2.8 ± 0.9 kg (4.0% ± 1.4%, P < 0.05) of body mass. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83737por Saeed, Kordo, Wilson, Darius Cameron, Bloos, Frank, Schuetz, Philipp, van der Does, Yuri, Melander, Olle, Hausfater, Pierre, Legramante, Jacopo M., Claessens, Yann-Erick, Amin, Deveendra, Rosenqvist, Mari, White, Graham, Mueller, Beat, Limper, Maarten, Callejo, Carlota Clemente, Brandi, Antonella, Macchi, Marc-Alexis, Cortes, Nicholas, Kutz, Alexander, Patka, Peter, Yañez, María Cecilia, Bernardini, Sergio, Beau, Nathalie, Dryden, Matthew, van Gorp, Eric C. M., Minieri, Marilena, Chan, Louisa, Rood, Pleunie P. M., del Castillo, Juan Gonzalez“…Patient subgroups with high MR-proADM concentrations (≥ 1.54 nmol/L) and low biomarker (PCT < 0.25 ng/mL, lactate < 2.0 mmol/L or CRP < 67 mg/L) or clinical score (SOFA < 2 points, qSOFA < 2 points, NEWS < 4 points or CRB-65 < 2 points) values were characterised by a significantly longer length of hospitalisation (p < 0.001), rate of ICU admission (p < 0.001), elevated mortality risk (e.g. SOFA, qSOFA and NEWS HR [95%CI], 45.5 [10.0–207.6], 23.4 [11.1–49.3] and 32.6 [9.4–113.6], respectively) and a greater number of disease progression events (p < 0.001), compared to similar subgroups with low MR-proADM concentrations (< 1.54 nmol/L). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83738por Vilella, Laura, Lacuey, Nuria, Hampson, Johnson P., Rani, M. R. Sandhya, Loparo, Kenneth, Sainju, Rup K., Friedman, Daniel, Nei, Maromi, Strohl, Kingman, Allen, Luke, Scott, Catherine, Gehlbach, Brian K., Zonjy, Bilal, Hupp, Norma J., Zaremba, Anita, Shafiabadi, Nassim, Zhao, Xiuhe, Reick-Mitrisin, Victoria, Schuele, Stephan, Ogren, Jennifer, Harper, Ronald M., Diehl, Beate, Bateman, Lisa M., Devinsky, Orrin, Richerson, George B., Tanner, Adriana, Tatsuoka, Curtis, Lhatoo, Samden D.“…PCCA duration was longer in males [HR 1.84, CI 95% (1.06–3.19), p = 0.003]. In 9/17 (52.9%) patients, PCCA was recurrent. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83739“…Intraoperative and postoperative medication side effects were recorded including bradycardia (HR <55 beats/min), hypotension (MAP <50 mmHg sustained for >10 min), oxygen desaturation (SpO2<90%), nausea, vomiting and prolonged sedation using Ramsay Sedation Score (RSS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83740“…DHEA-S was 34.1 mcg/dL (20.8 - 226.4), Renin was 11.5 ng/mL/hr (0.2-5.4) and Aldosterone was < 1.0 ng/dL (0-30). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto